(2020) HIV-Tuberculous Meningitis Co-infection: A Systematic Review and Meta-analysis. Curr Pharm Biotechnol. ISSN 1389-2010
Full text not available from this repository.
Abstract
Human immunodeficiency virus (HIV)-infected persons are at a higher risk of developing Tuberculous meningitis (TBM). We aimed to estimate the prevalence of TBM-HIV co-infection. We systematically searched Pubmed/Medline, Embase and Cochrane library databases from January 1, 2000, to January 31, 2017, to find relevant studies. We employed the random-effects meta-analysis model to estimate the pooled prevalence of TBM-HIV co-infection. Twenty-six eligible studies showed the prevalence of HIV in TBM patients. In the pooled analyses, the prevalence of HIV was 30 (95 CI: 12-47) in patients with confirmed TBM, and 12.1 (95 CI: 7.3-19.2) in patients with suspected TBM. This study shows a high prevalence of TBM-HIV co-infection. Establishing proper diagnostic criteria and preventive measures for TBM infections could assist in the prevention and management of TBM infection, particularly TBM-HIV co-infection.
Item Type: | Article |
---|---|
Keywords: | Hiv Meta-analysis Mycobacterium tuberculosis Tbm meningitis prevention. |
Journal or Publication Title: | Curr Pharm Biotechnol |
Journal Index: | Pubmed |
Identification Number: | https://doi.org/10.2174/1389201021666200730143906 |
ISSN: | 1389-2010 |
Depositing User: | مهندس مهدی شریفی |
URI: | http://eprints.bmsu.ac.ir/id/eprint/9094 |
Actions (login required)
View Item |